Author

J. M. Swain

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

D. MURIAUX· 4 shared M. Gourdelier· 2 shared P. Merida· 2 shared S. Lyonnais· 2 shared A. Bienvenu· 1 shared A. Makinson· 1 shared A. Mouttou· 1 shared A. Neyret· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

D. MURIAUX

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The multifunction Coxiella effector Vice stimulates macropinocytosis and interferes with the ESCRT machinery

A. Bienvenu, M. Burette, F. Cantet, M. Gourdelier, J. M. Swain, C. Cazevieille, T. Clemente, A. Sadi, C. Dupont, M. Le Fe, N. Bonetto, B. Bordignon, D. MURIAUX, S. D. Gilk, M. Bonazzi, E. Martinez

This study identifies the Coxiella effector Vice as a protein that manipulates host cell lipid composition and cellular pathways to form the Coxiella-containing vacuole.

bioRxiv · Mar 13, 2024 · PreprintMicrobiology

Specific targeting and clustering of Phosphatidylserine lipids by RSV M protein is critical for virus particle production

J. M. Swain, M. Bierre, L. Veyrie, C.-A. Richard, J.-F. Eleouet, D. MURIAUX, M. Bajorek

This study shows RSV M protein binds phosphatidylserine lipids, promoting viral assembly, and identifies lipid interactions critical for virus production.

bioRxiv · Mar 13, 2023 · PreprintBiochemistry

Optimized production and fluorescent labelling of SARS-CoV-2 Virus-Like-Particles to study virus assembly and entry.

D. Muriaux, M. Gourdelier, J. M. Swain, C. Arone, A. Mouttou, D. Bracquemond, P. Merida, S. Saffarian, S. Lyonnais, C. Favard

This paper optimizes the production of SARS-CoV-2 Virus-Like Particles (VLPs) and demonstrates their fluorescent labeling for studying virus assembly and entry mechanisms.

bioRxiv · Mar 23, 2022 · PreprintMicrobiology

Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19.

C. Chable-Bessia, C. Boulle, A. Neyret, J. M. Swain, M. Henaut, P. Merida, N. Gros, A. Makinson, S. Lyonnais, C. B. Chesnais, D. Muriaux

This study evaluates the anti-SARS-CoV-2 activity of ivermectin and other macrocyclic lactones in vitro, finding low selectivity indices that suggest limited therapeutic potential for COVID-19.

bioRxiv · Nov 1, 2021 · PreprintMicrobiology